Sonoma Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Sonoma Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Sonoma Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$610K, a 58.9% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.69M, a 40.1% increase year-over-year.
  • Sonoma Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.84M, a 6.14% increase from 2022.
  • Sonoma Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$5.15M, a 1.28% decline from 2021.
  • Sonoma Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$5.09M, a 28.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.69M -$610K +$874K +58.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$4.56M -$1.14M +$275K +19.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$4.84M -$1.07M +$241K +18.4% Jan 1, 2024 Mar 31, 2024 10-K 2024-06-17
Q4 2023 -$5.08M -$866K +$1.07M +55.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 -$6.15M -$1.48M -$467K -45.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$5.68M -$1.42M -$531K -59.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$5.15M -$1.31M +$1.64M +55.6% Jan 1, 2023 Mar 31, 2023 10-K 2024-06-17
Q4 2022 -$6.79M -$1.94M -$995K -105% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 -$5.79M -$1.02M -$917K -917% Jul 1, 2022 Sep 30, 2022 10-Q 2024-02-08
Q2 2022 -$4.88M -$887K +$211K +19.2% Apr 1, 2022 Jun 30, 2022 10-Q 2024-02-08
Q1 2022 -$5.09M -$2.94M +$716K +19.6% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-21
Q4 2021 -$5.8M -$944K -$294K -45.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-14
Q3 2021 -$5.51M -$100K -$220K -183% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$5.29M -$1.1M -$1.34M -558% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$3.95M -$3.66M -$1.92M -111% Jan 1, 2021 Mar 31, 2021 10-K 2022-07-13
Q4 2020 -$2.03M -$650K +$434K +40% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q3 2020 -$2.46M $120K +$1.32M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3.78M $240K -$475K -66.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$3.31M -$1.74M +$1.49M +46.1% Jan 1, 2020 Mar 31, 2020 10-K 2021-07-14
Q4 2019 -$4.79M -$1.08M +$1.21M +52.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-16
Q3 2019 -$6.01M -$1.2M +$1.62M +57.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-20
Q2 2019 -$7.63M $715K +$4.17M Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-11-17
Q1 2019 -$11.8M -$3.22M +$1.54M +32.4% Jan 1, 2019 Mar 31, 2019 10-K 2020-07-10
Q4 2018 -$13.3M -$2.3M +$889K +27.9% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 -$14.2M -$2.82M +$50K +1.74% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$14.3M -$3.46M +$50K +1.43% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$14.3M -$4.76M -$2.33M -95.4% Jan 1, 2018 Mar 31, 2018 10-K 2019-07-01
Q4 2017 -$12M -$3.19M -$19.4M -120% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 $7.41M -$2.87M -$921K -47.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $8.33M -$3.51M -$940K -36.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $9.27M -$2.44M +$473K +16.3% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-26
Q4 2016 $8.8M $16.2M +$19.4M Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 -$10.6M -$1.95M -$186K -10.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$10.4M -$2.57M -$228K -9.74% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$10.2M -$2.91M -$1.41M -93.9% Jan 1, 2016 Mar 31, 2016 10-K 2017-06-28
Q4 2015 -$8.75M -$3.15M +$2.77M +46.8% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-17
Q3 2015 -$11.5M -$1.76M -$1.05M -146% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 -$10.5M -$2.34M -$2.27M -3243% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$8.2M -$1.5M -$8.96M -120% Jan 1, 2015 Mar 31, 2015 10-K 2016-06-21
Q4 2014 $755K -$5.91M -$5.3M -868% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-16
Q3 2014 $6.06M -$718K +$681K +48.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 $5.38M -$70K +$1.64M +95.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $3.74M $7.46M +$9.9M Jan 1, 2014 Mar 31, 2014 10-K 2015-06-16
Q4 2013 -$6.17M -$611K +$1.3M +68% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-12
Q3 2013 -$7.47M -$1.4M +$120K +7.9% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$7.59M -$1.71M -$2.16M -485% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$5.43M -$2.45M -$677K -38.3% Jan 1, 2013 Mar 31, 2013 10-K 2014-06-30
Q4 2012 -$4.75M -$1.91M +$635K +24.9% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 -$5.39M -$1.52M -$680K -81% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-19
Q2 2012 -$4.71M $445K +$2.62M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$7.33M -$1.77M -$74K -4.37% Jan 1, 2012 Mar 31, 2012 10-K 2013-06-25
Q4 2011 -$7.26M -$2.55M -$317K -14.2% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-13
Q3 2011 -$6.94M -$839K +$810K +49.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 -$7.75M -$2.18M +$200K +8.42% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-31
Q1 2011 -$7.95M -$1.69M Jan 1, 2011 Mar 31, 2011 10-K 2012-06-21
Q4 2010 -$2.23M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-10
Q3 2010 -$1.65M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 -$2.38M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.